14 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Lupus Foundation of America 2012 Gina M. Finzi Memorial Student Summer Fellowship Program
LFA announces the opening of the 2012 Gina M. Finzi Memorial Student Summer Fellowship program competition.
What You Need to Know
Awards in the amount of $4,000 Duration of award: Summer 2012 Application deadline: March 30, 2012 at 5 p.m. EST Notification date: May 11, 2012
ELIGIBILITY Although undergraduate students may apply, preference will be given to graduate or medical students who have already earned a baccalaureate degree or will have done so prior to their official acceptance of the award. Please note that awards cannot be postponed for use in a later year.
Online Application
Applicants are encouraged to register and complete a professional profile at proposalCENTRAL as soon as possible. Applicants should ensure that their grants and contracts office has registered their institutional, financial, and signing officials with proposalCENTRAL.
LFA uses an electronic grants submission process. All interested grant applicants must submit their full application packages through proposalCENTRAL at the following webpage: https://proposalcentral.altum.com/. A proposalCENTRAL helpline is available for questions from applicants, Monday – Friday, 8:30 a.m. – 5:30 p.m., EST. Customer support is available via phone at 1-800-875-2562 or by email at pcsupport@altum.com. The Gina M. Finzi Memorial Student Summer Fellowship Program
Purpose
The purpose of the Gina M. Finzi Memorial Student Summer Fellowship Program is to foster an interest among students in the areas of basic, clinical, translational, epidemiological, or behavioral research relevant to lupus under the sponsorship and supervision of an established, tenure-track Principal Investigator who directs a laboratory dedicated at least in part to the investigation of lupus at a U.S. academic, medical, or research institution.
Biomedical research on lupus has not kept pace with research efforts put forth to advance knowledge about treatments for other chronic and life-threatening diseases. The Gina M. Finzi Memorial Student Summer Fellowship Program is part of LFA’s ongoing efforts to advance the science and medicine of lupus and bring down the barriers that have impeded progress in lupus research for decades.
History
The Gina M. Finzi Memorial Student Summer Fellowship Program is a memorial tribute to Gina M. Finzi, the late daughter of former LFA President Emeritus Sergio Finzi, Ph.D. Since 1984, the Gina M. Finzi Memorial Student Summer Fellowship Program has supported the work of nearly 200 young investigators.
Over the years, participants in this valued fellowship program have produced numerous publications in respected peer-reviewed journals such as Journal of Immunology, Arthritis & Rheumatism, Lupus, Stroke, and European Journal of Immunology. Some have also earned M.D. or Ph.D. degrees and have become medical practitioners or academic researchers.
Finzi Fellowship Benefits
Financial support for a summer research project Opportunities for professional training, enrichment, and mentorship Exclusive membership to LFA-sponsored LinkedIn® Group for Finzi Fellows Lifetime professional association with LFA network Access to LFA professional resources
Lupus Foundation of America, Inc. 2000 L Street, N.W., Suite 410 Washington, DC 20036 Phone: 202-349-1155 Fax: 202-349-1156
Epilepsy Foundation Targeted Research Initiative for Youth
Application Deadline: March 21, 2012
Award Amount: up to $50,000 maximum for one year
Apply via Proposal Central website
The Targeted Research Initiative for Youth grant program recognizes the increasing need for epilepsy and seizure research in populations from birth through the teen years involving pathophysiology, epidemiology, diagnosis, behavioral manifestations, medication therapy, and quality-of-life issues.
The Foundation invites research grant applications from investigators interested in psychosocial problems and comorbidities of infants, children and adolescents with epilepsy including, but not limited to topics such as psychiatric comorbidity; treatment of behavioral and cognitive comorbidities, including innovative techniques such as utilization of internet or computer based technologies; studies of the impact of impaired social cognition on educational and occupational outcomes; difficulties and treatment gaps for adolescents transitioning to adulthood; social supports for adolescents with epilepsy; health access and literacy including family communication with health care professionals; the impact of other health conditions (e.g. sleep difficulties, migraines, etc.) on epilepsy treatment and outcome.
Applicants may request up to $50,000 maximum for one year.
Epilepsy Foundation 8301 Professional Place Landover, MD 20785-7223 Telephone: 1-800-332-1000 Fax: 1-301-577-2684 Email: ContactUs@efa.org
Call for Applications: Orthopaedic Research and Education Foundation Prospective Clinical Research Grant in Spine Care
Applications due March 8, 2012
Spine surgeons who are board-certified in neurosurgery and/or orthopaedic surgery are invited to apply for up to $300,000 ($50,000-$100,000 per year for up to three years) in grant support to further the work of individual investigators, investigator networks, single institutions, or consortia of institutions conducting prospective clinical research. Grants will in spine care in any of the following study areas:
spinal deformity—adult deformity outcomes, spondylolisthesis, pediatric scoliosis, pediatric kyphosis, and early onset scoliosis; spine trauma—epidemiology, process and outcomes of spinal injuries, surgical treatment of acute spinal cord injury); degenerative spinal disorders—prospective outcomes for surgical and non-surgical treatments of lumbar, cervical, and thoracic degenerative spinal disorders; spinal oncology (epidemiology, process and outcomes of primary and metastatic spinal tumors);and non-surgical interventions for the treatment of spine injuries and disorders, including diagnostic, public health and rehabilitative methodologies.
Grants will be awarded to qualified recipients based on satisfaction of published eligibility and application requirements, and independent peer review. Peer review teams of spine surgeons and spine care investigators will be assembled by OREF and directed by OREF’s Advisory Committee on Clinical Research in Spine Care in accordance with OREF peer review standards and procedures, comprising neurosurgeons and orthopaedic surgeons who are appointed solely by OREF. Completed applications are due to OREF by March 8, 2012, funding to begin May 1, 2012.
These grants are made possible by support from Medtronic Sofamor Danek, USA, Inc. As is the case for all OREF donors, Medtronic has no influence on disbursement or management of funds; the composition OREF staff or its board or committees; content of program communications; any aspect of grant administration, application review or selection of funded proposals/recipients; conduct of program activities; or dissemination of findings from funded projects.
For more information please contact:
Jean McGuire, V.P., Grants (847) 384-4348 Mary Marino, Grants Administrator (847) 384-4359
Call for Applications: Scleroderma Foundation Established Investigator Grant
Grant Application Deadline: Sept. 15th annually by 5 p.m. EST
If the 15th falls on a Sat. or Sun., then the following Monday at 5 p.m. EST will be the deadline.
Purpose: The Scleroderma Foundation is seeking applications from promising established investigators both inside and outside the field of SSc research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to SSc. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources.
Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are eligible. Applicants must have a doctorate degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences, must have completed a postdoctoral fellowship, have been Principal Investigator on grants from the Scleroderma Foundation or other national, private or government agencies in the past.
Investigators who have questions about eligibility should contact the Scleroderma Foundation (see below).
Mechanism of Support: Applicants may request up to $75,000 (Up to 8% of the Direct Costs per year of award may be set aside as indirect costs. The indirect cost amount will be subtracted from the yearly total [up to $75,000) of the award) per year for up to two years (total for 2 years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek more substantial continuing support for research through other grant mechanisms through private or government agencies. Replacement of the Principal Investigator on this award is not permitted. There will be no routine escalation for future years.
Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications meeting the stated eligibility requirements.
Research Objectives: The Scleroderma Foundation Innovative Grant is designed to facilitate highly innovative or highly relevant and meritorious pilot projects by established investigators in areas of research related to SSc that will culminate in more substantial funding from Federal or non-federal granting agencies such as the National Institutes of Health, National Science Foundation and the Department of Defense or Veterans Affairs.
Appropriate research areas may include but are not limited to the following as they relate to scleroderma:
Vascular manifestations. Studies of animal models. Therapeutic modalities. Mechanisms of end organ damage. Immunologic studies. Endothelial cell biology. Fibroblast biology. Models and markers of gender and genetic factors. Cell signaling. Epidemiology studies. Matrix biology. Stem cell biology. Health services research (e.g. quality of life, health care delivery.) Study of clinical manifestation.
Scleroderma Foundation 300 Rosewood Drive, Suite 105 Danvers, MA 01923
Phone: (978) 463-5843 (8:30 a.m. to 5 p.m. ET, Monday through Friday) Fax: (978) 463-5809 Toll-free: (800) 722-HOPE (4673)
Call for Applications: Scleroderma Foundation New Investigator Grant
Purpose: The Scleroderma Foundation is seeking applications from promising new investigators who hold faculty or equivalent positions and who wish to pursue a career in research related to systemic sclerosis (SSc, scleroderma). This grant will support promising research that is likely to lead to individual research project grants.
Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are not eligible. These new investigator grants may not be used to support thesis or dissertation research or fellowship training. Applicants must have a doctoral degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences and must have completed a postdoctoral fellowship by the grant award date. Applicants who have been a Principal Investigator on grants from the Scleroderma Foundation or other national, private or government agencies other than fellowship grants are not eligible for this award.
Mechanism of Support: Applicants may request up to $50,000 (Up to 8% of the Direct Costs per year of award may be set aside as indirect costs. The indirect costs will be subtracted from the yearly total (up to $50,000) of the award.) per year for up to three years (total for three years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek continuing support for research through other grant mechanisms through private or government agencies. Replacement of the Principal Investigator on this award is not permitted. There will be no routine escalation for future years.
Research Objectives: The Scleroderma Foundation New Investigator Grant is designed to facilitate the entry of promising new investigators into areas of research related to SSc.
Request for Manuscripts for Consideration for the Society for Pediatric and Perinatal Epidemiologic Research Student Prize Paper Award
Deadline: March 2, 2012
The Society for Pediatric and Perinatal Epidemiologic Research (SPER) requests manuscript for consideration for the annual Student Prize Paper Award. This competition is open to graduate and medical students, postdoctoral fellows, medical residents, research trainees, and clinical fellows interested in reproductive, perinatal, and pediatric epidemiology. The winner of the award will present the selected paper at the SPER Annual Meeting.
An award of $500 plus expenses for travel, two days lodging, and SPER Annual Meeting registration will be given to the author of the selected paper. The paper should represent work in reproductive, perinatal, or pediatric epidemiology conducted as a student or trainee during the two years prior to the upcoming meeting. The paper must be written by the student/trainee and must be unpublished at the time of the meeting. The submitted manuscript should be prepared according to the Author Guidelines in the journal Paediatric and Perinatal Epidemiology.
The author may submit the paper simultaneously to the Abraham Lilienfeld Student Prize Paper competition of the Society for Epidemiologic Research (SER); however, if the paper is selected for that award, it will not be eligible for the SPER award. Authors do not have to be members of SPER to apply.
Please note: Applicants must also submit the abstract of their paper via the regular Annual Meeting call for abstracts to ensure consideration for the program should their manuscript not be selected for the award.
To apply for this award, please submit the following materials in electronic format to the Society’s Secretary by March 2, 2012:
1. A cover letter indicating the name of the student or trainee, the title of the paper, academic affiliation and name of the mentor. 2. Manuscript in PPE format 3. Letter of support from mentor under whom the work was completed indicating student or trainee’s specific contribution
Request for Submissions: Society for Pediatric and Perinatal Epidemiologic Research Heinz Berendes International Travel Award
The Society for Pediatric and Perinatal Epidemiologic Research (SPER) requests submissions of manuscripts for the Heinz Berendes International Travel Award. The manuscript should represent work in reproductive, perinatal, or pediatric epidemiology, and research that concerns populations in developing countries is encouraged.
To be eligible for this award, the applicant SHOULD HAVE COMPLETED THIS WORK OUTSIDE OF THE UNITED STATES OR CANADA, AND SHOULD NOT HAVE RESIDED IN THE UNITED STATES OR CANADA. The paper must be unpublished at the time of submission. Authors do not have to be SPER members to apply for the award but are asked to join SPER if selected for presentation. The winner will present the selected paper at the SPER Annual Meeting.
An award of $250 plus expenses for travel, 2 days lodging, and SPER Annual Meeting registration will be given to the author of the paper selected by the International Travel Award Committee. The submitted manuscript should be prepared according to the Author Guidelines in the journal Paediatric and Perinatal Epidemiology. You will also be asked to provide the name and address of your academic affiliation or research establishment and your country of residence in the previous six months.
A cover letter indicating the name of the applicant, title of the paper, academic affiliation or research establishment, and country of residence for the previous six months. Manuscript in PPE format
Swiss Society for Infectious Diseases/International Society for Infectious Diseases Infectious Diseases Research Fellowship Program
ISID and the Swiss Society for Infectious Diseases (SSI) jointly sponsor the SSI/ISID Infectious Diseases Research Fellowship Program.
The purpose of this Fellowship Program is to support infectious disease physicians and scientists from developing and middle income countries through multidisciplinary clinical and laboratory training at select biomedical institutions in Switzerland. The objectives of the Fellowship Program are:
to train promising young physicians and scientists from developing and middle income countries for clinical and research positions in infectious diseases, to foster partnerships between Fellows and infectious disease leaders in Switzerland, and to increase scientific research capacity in low income/high disease burden countries.
Opportunities for training and research in a variety of areas ranging from basic studies of the mechanism of disease to studies in public health, epidemiology, diagnostics, therapeutics or vaccine development, are available through this program.
The term of the Fellowship is for one year. The start date of the will be determined by arrangement between the host institution and the Fellow.
A financial stipend of up to 36,000 SF per year (approximately $21,000 USD) will be given to Fellows to cover travel costs and living expenses. The program intends to award two fellowships every year.
IMPORTANT NOTICE: Language skills of French or German are necessary according to the institution chosen (German for Basel, Bern, Zurich and St. Gallen; French for Geneva and Lausanne). Please indicate in your application your speaking and writing proficiency of these languages and of English.
return to top Training Sites SSI/ISID Fellows will be placed at one of six collaborating research centers in Switzerland according to technical interests and skills. All infectious diseases programs at each institution offer experience in clinical infectious diseases, including HIV, and microbiology. The technical research interests at each site include:
Bern: Meningitis. Brain injury in CNS infection. Molecular pathogenesis of respiratory pathogens. Epidemiology and resistance of pneumococcus. (Tauber MG, Leib SL, Aebi C, Muhlemann K)
Geneva: Clinical trials in hospital infections and HIV infection. Hospital hygiene and epidemiology. Genomics, molecular biology, and pathogenicity of S. aureus. Foreign body infections. (Lew D, Garbino J, Pittet D, Perrin L, Hirschel B,Vaudaux P, Schrenzel J, Kelley W, ) [additional information is available at http://www.geneve-infection.ch/]
Lausanne: Mechanisms of antibiotic resistance. Molecular pathogenesis of endocarditis. Cytokines and sepsis. Resistance, pharmaco-epidemiology, and therapeutic drug monitoring in HIV. Molecular epidemiology of nosocomial infections. Antibiotic use. (Glauser M, Calandra T, Moreillon P, Telenti A, Francioli P, Zanetti G)
Basel: Infectious diseases, hospital hygiene and epidemiology. Full clinical service in all areas of infection diseases and hospital hygiene and epidemiology. Pathophysiology and clinical research including health economy. HIV: pathogenesis and course of disease. (Battegay M, Flckiger U, Widmer A, Erb P) [additional information is available at http://www.kantonsspital- basel.ch]
Zurich: Clinical trials in HIV. Molecular biology of HIV, latent reservoirs, and anti-HIV immune response. HIV epidemiology. Intestinal infections. Zoonotic infections. Hospital epidemiology. (Weber R, Ruef C, Guenthart H, Opravil M, Trkola A, Flepp M, Speck R, Ledergerber B)
St. Gallen: Sexual transmission of HIV (Vernazza P). [additional information is available at http://www.infekt.ch]
Eligibility The program is open to applicants who are citizens or permanent residents of developing countries or Eastern Europe. Applicants should have a M.D. or a Ph.D in a relevant field and should hold a position at a medical, research, or public health institution. An endorsement by the home institution is required for participation in the program.
Applications will be reviewed by a joint SSI and ISID committee. Selection will be based on the applicant's academic potential, career plans, previous clinical/research experience, letters of reference, and relevance of training to home institution and home country. Personal interviews will be arranged with selected applicants as the final step in the application process.
The annual application deadline for Fellowship applications is 1 April. All applicants will be notified of the outcome of their application by 1 July.
Requests for application materials and additional information should be directed to:
ISID Professional Development Working Group 1330 Beacon Street, Suite 228 Brookline, Massachusetts 02446 USA
Fax: (617) 731-1541 E-mail: info@isid.org
International Society for Infectious Diseases Small Grants Program
The Small Grants Program is designed to fund pilot research projects by young investigators in developing countries. The goal is to support and foster the professional development of young individuals in the field of infectious diseases research by helping them to acquire additional skills and data to apply for other grants. Areas of interest include, but are not limited to investigations of the epidemiology, pathophysiology, diagnosis or treatment of infectious diseases, the epidemiology and control of hospital-acquired infections, and modeling of cost effective interventions.
Proposals will be reviewed by members of the Professional Development Working Group and decisions made in collaboration with the President and the Program Director.
Upon completion of the project, a written report of the project must be sent to the Society. The Society encourages recipients of grants to present their results at scientific meetings and to submit them for publication in peer-reviewed journals.
Deadlines Up to five grants of up to US $6,000 each will be awarded annually. Deadlines for submission of proposals are April 1 (notification after June 1) and October 1 (notification after December 1).
2012 Senior Scholar in Aging Award
The Ellison Medical Foundation was established and is supported by Lawrence J. Ellison to support biomedical research (including basic biology, basic biomedicine and epidemiology) on aging. The Ellison Medical Foundation Senior Scholar program is designed to support established investigators, working at institutions in the U.S., to conduct research in the basic biological and basic biomedical sciences relevant to understanding lifespan development processes and age-related diseases and disabilities. The award is intended to provide significant support to established investigators in order to allow the development of new, creative research programs by investigators who may not currently be conducting aging research or who may wish to develop new research programs in aging. The Foundation particularly wishes to stimulate new research, which has rigorous scientific foundations, but which may not be currently funded adequately, because of its perceived novelty, its high risk, or because it is from an area where traditional research interests absorb most funding.
Areas of interest include, but are not limited to
Structural biology Molecular genetics Studies with model systems ranging from lower eukaryotes to humans Inquiries testing the relevance of simpler models to human aging Genetic epidemiology of aging; candidate longevity genes Aging in the immune system Host defense molecules in aging systems Mechanisms of free radical induced cell aging Mechanisms of aging in various differentiated cell populations Gene/environment and gene/gene interactions Integrative physiology New approaches to age-modulated disease mechanisms
Eligibility
Any interested researcher may submit a Letter of Intent for the 2012 Senior Scholar in Aging award competition; however, current or past Senior Scholar Awardees are not eligible. Applicants for the Senior Scholar Award are expected to furnish evidence of substantial prior scientific creativity and productivity not necessarily targeted to aging heretofore. Evaluation by the Aging Review Group and the Scientific Advisory Board will be based upon the applicant's submission re: scientific contributions to date, the quality of publications, and the importance to aging of the proposed new research. The Aging Review Group and the Scientific Advisory Board will pay close attention to arguments as to why the work does not or would not qualify for support from established sources such as the NIA. Except for compelling circumstances, the awards are not intended to supplement ongoing, already funded programs but, instead, to inspire new directions, which may entail substantial risk. There is no limit on the number of Senior Scholar letters of intent from any one institution. Up to 25 Senior Scholar awards will be made in 2012.
Letter of Intent for Submitting an Application
Instructions and a link to submit a Letter of Intent online for the 2012 application cycle appear on the Applications and Receipt Dates page.
Letters of Intent are due by March 8, 2012 (online submissions must be completed by 11:59 p.m. Eastern Standard Time).
Terms of the Award
The Ellison Medical Foundation Senior Scholar Awards in Aging will be made in early October 2012. Each award will be made for up to $150,000 per year direct cost, plus indirect costs, for up to four years. Funding for years two, three and four is contingent upon submission of an acceptable progress report.
Acceptable uses for award funds include project-related: salaries, other personnel costs, equipment, supplies, resource acquisition and travel. Carry-overs in excess of $25,000 must be approved by the Ellison Medical Foundation Scholars Program Office. Full indirect costs at the NIH Facilities and Administration (F & A) negotiated rate will be provided. The Ellison Medical Foundation does not permit indirect costs on equipment, even for purchases less than $5,000, for initial awardee years of 2005 and later.
For all (new and non-competing renewal) awards supporting research involving human subjects, animal subjects, research collaborations with foreign institutions, biosafety issues, or embryonic stem cells the Foundation will require the following documentation before an award can be made:
Human subjects:
Copies of the protocol submitted to the Institutional Review Board(s)for this project* and the notification of protocol approval from all relevant IRBs (for funded awards an annual update will be required at the time of the progress report). Documentation from the applicant institution that the principal investigator has completed training on the protection of human research participants.
Animal subjects:
A copy of Institutional Animal Care and Use Committee approval for this project* (an annual update will be required at the time of each progress report).
Foreign component:
A letter of support from the collaborating in-country institution.
Biosafety:Research supported by the Ellison Medical Foundation is expected to conform to the relevant NIH Guidelines for biosafety, including those for handling of hazardous reagents and those for research involving recombinant DNA and gene transfer http://oba.od.nih.gov/rdna/nih_guidelines_oba.html . A copy of Institutional Biosafety Committee approval for this project* .
Embryonic Stem Cell Research Committee approval of the protocol for this project* if it involves human embryonic stem cells.
* Approval for this project means the EMF funded project, not a similar protocol funded by some other entity.
For further information, contact:
Richard L. Sprott, Ph.D. Executive Director The Ellison Medical Foundation 4710 Bethesda Avenue Suite 204 Bethesda, MD 20814-5226 (301) 657-1830 (Phone) (301) 657-1828 (Fax) rsprott@ellisonfoundation.org
12next
